Cargando…
The using of a piglets as a model for evaluating the dipyrone hematological effects
BACKGROUND: Dipyrone (MET, metamizole) is a non-steroidal anti-inflammatory drug commonly used both in human and in veterinary medicine. After oral administration, is broken down rapidly to metabolites which largely retain the activity of the parent drug. Its metabolites have analgesic, antipyretic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123311/ https://www.ncbi.nlm.nih.gov/pubmed/27884143 http://dx.doi.org/10.1186/s12917-016-0891-5 |
_version_ | 1782469708148113408 |
---|---|
author | Burmańczuk, Artur Milczak, Andrzej Grabowski, Tomasz Osypiuk, Monika Kowalski, Cezary |
author_facet | Burmańczuk, Artur Milczak, Andrzej Grabowski, Tomasz Osypiuk, Monika Kowalski, Cezary |
author_sort | Burmańczuk, Artur |
collection | PubMed |
description | BACKGROUND: Dipyrone (MET, metamizole) is a non-steroidal anti-inflammatory drug commonly used both in human and in veterinary medicine. After oral administration, is broken down rapidly to metabolites which largely retain the activity of the parent drug. Its metabolites have analgesic, antipyretic and anti-inflammatory effects. RESULTS: The subjects were eight healthy male Large White post-suckling piglets, weighing between 5.0 to 7.4 kg, of ages 35 ± 10 days. The animals were administered MET (100 mg/kg) by an intramuscular (I.M.) injection. The study calculated the value of several hemorheological parameters. Significant impact of MET treatment (p < 0.05) was proven in case: activated partial thromboplastin time; ratio of activated partial thromboplastin time; hemoglobin; hematocrit; mean corpuscular hemoglobin; mean corpuscular volume; red blood cells volume; white blood cells volume; prothrombin time index. CONCLUSIONS: In summation, our observations suggest that a piglet model is useful for studying the impact of MET on hemorheological parameters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-016-0891-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5123311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51233112016-12-06 The using of a piglets as a model for evaluating the dipyrone hematological effects Burmańczuk, Artur Milczak, Andrzej Grabowski, Tomasz Osypiuk, Monika Kowalski, Cezary BMC Vet Res Research Article BACKGROUND: Dipyrone (MET, metamizole) is a non-steroidal anti-inflammatory drug commonly used both in human and in veterinary medicine. After oral administration, is broken down rapidly to metabolites which largely retain the activity of the parent drug. Its metabolites have analgesic, antipyretic and anti-inflammatory effects. RESULTS: The subjects were eight healthy male Large White post-suckling piglets, weighing between 5.0 to 7.4 kg, of ages 35 ± 10 days. The animals were administered MET (100 mg/kg) by an intramuscular (I.M.) injection. The study calculated the value of several hemorheological parameters. Significant impact of MET treatment (p < 0.05) was proven in case: activated partial thromboplastin time; ratio of activated partial thromboplastin time; hemoglobin; hematocrit; mean corpuscular hemoglobin; mean corpuscular volume; red blood cells volume; white blood cells volume; prothrombin time index. CONCLUSIONS: In summation, our observations suggest that a piglet model is useful for studying the impact of MET on hemorheological parameters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-016-0891-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-25 /pmc/articles/PMC5123311/ /pubmed/27884143 http://dx.doi.org/10.1186/s12917-016-0891-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Burmańczuk, Artur Milczak, Andrzej Grabowski, Tomasz Osypiuk, Monika Kowalski, Cezary The using of a piglets as a model for evaluating the dipyrone hematological effects |
title | The using of a piglets as a model for evaluating the dipyrone hematological effects |
title_full | The using of a piglets as a model for evaluating the dipyrone hematological effects |
title_fullStr | The using of a piglets as a model for evaluating the dipyrone hematological effects |
title_full_unstemmed | The using of a piglets as a model for evaluating the dipyrone hematological effects |
title_short | The using of a piglets as a model for evaluating the dipyrone hematological effects |
title_sort | using of a piglets as a model for evaluating the dipyrone hematological effects |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123311/ https://www.ncbi.nlm.nih.gov/pubmed/27884143 http://dx.doi.org/10.1186/s12917-016-0891-5 |
work_keys_str_mv | AT burmanczukartur theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT milczakandrzej theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT grabowskitomasz theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT osypiukmonika theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT kowalskicezary theusingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT burmanczukartur usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT milczakandrzej usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT grabowskitomasz usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT osypiukmonika usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects AT kowalskicezary usingofapigletsasamodelforevaluatingthedipyronehematologicaleffects |